​

Funding Round

Series B - evonetix

Series B - evonetix

Investment Firm

Overview

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Announced Date

Feb 07, 2023

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Foresite Capital

Foresite Capital

Foresite Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

6

Investor Name
Participant InvestorCambridge Consultants
Participant InvestorMorningside Group
Participant InvestorForesite Capital
Participant InvestorDCVC
Participant InvestorMolten Ventures

Round Details and Background

evonetix raised $24108294 on 2023-02-07 in Series B

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 30, 2018
Series A - evonetix
6-12.3M
Jul 02, 2018
Grant - evonetix
1-1.7M
Mar 02, 2020
Series B - evonetix
8-30.0M
Feb 07, 2023
Series B - evonetix
8-24.1M

Recent Activity

There is no recent news or activity for this profile.